Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection

Víctor Monforte; Helena Sintes; Piedad Ussetti; Raquel Castejón; Virginia Luz Pérez; Rosalía Laporta; Amparo Sole; José Manuel Cifrián; Pedro J Marcos; Javier Redel; Ibai Los Arcos; Berta Sáez; Rodrigo Alonso; Silvia Rosado; Juan Escriva; David Iturbe; Juan Pablo Ovalle; José Manuel Vaquero; Eva Revilla; Alberto Mendoza; Susana Gómez-Ollés

doi:10.1016/j.arbres.2021.10.002

Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection

Arch Bronconeumol. 2022 Aug;58(8):614-617. doi: 10.1016/j.arbres.2021.10.002. Epub 2021 Oct 25.

[Article in English, Spanish]

Authors

Víctor Monforte¹, Helena Sintes², Piedad Ussetti³, Raquel Castejón⁴, Virginia Luz Pérez⁵, Rosalía Laporta³, Amparo Sole⁶, José Manuel Cifrián⁷, Pedro J Marcos⁸, Javier Redel⁹, Ibai Los Arcos¹⁰, Berta Sáez², Rodrigo Alonso⁵, Silvia Rosado⁴, Juan Escriva⁶, David Iturbe⁷, Juan Pablo Ovalle⁸, José Manuel Vaquero⁹, Eva Revilla², Alberto Mendoza², Susana Gómez-Ollés¹¹

Affiliations

¹ Respiratory Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: vmonforte@vhebron.net.
² Respiratory Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
³ Respiratory Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
⁴ Laboratory of Internal Medicine Department, Instituto de Investigación Sanitaria Puerta de Hierro, Madrid, Spain.
⁵ Respiratory Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
⁶ Lung Transplant Unit, Hospital Universitario y Politécnico la Fe, Valencia, Spain.
⁷ Respiratory Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
⁸ Care Process Management, Respiratory Department and Thoracic Surgery, Área Sanitaria de A Coruña y CEE, A Coruña, Spain.
⁹ Respiratory Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
¹⁰ Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Department of Infectious Diseases, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
¹¹ Respiratory Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

PMID: 35312499
DOI: 10.1016/j.arbres.2021.10.002

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / therapeutic use
Cytomegalovirus Infections* / diagnosis
Cytomegalovirus Infections* / drug therapy
Humans
Kidney Transplantation*
Lung
Transplant Recipients

Substances

Antiviral Agents